Cargando…
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542228/ https://www.ncbi.nlm.nih.gov/pubmed/37775828 http://dx.doi.org/10.1186/s13046-023-02824-9 |
| _version_ | 1785114049058439168 |
|---|---|
| author | Teng, Fei Zhang, Ju-Xiang Chang, Qi-Meng Wu, Xu-Bo Tang, Wei-Guo Wang, Jian-Fa Feng, Jin-Feng Zhang, Zi-Ping Hu, Zhi-Qiu |
| author_facet | Teng, Fei Zhang, Ju-Xiang Chang, Qi-Meng Wu, Xu-Bo Tang, Wei-Guo Wang, Jian-Fa Feng, Jin-Feng Zhang, Zi-Ping Hu, Zhi-Qiu |
| author_sort | Teng, Fei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10542228 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105422282023-10-03 Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma Teng, Fei Zhang, Ju-Xiang Chang, Qi-Meng Wu, Xu-Bo Tang, Wei-Guo Wang, Jian-Fa Feng, Jin-Feng Zhang, Zi-Ping Hu, Zhi-Qiu J Exp Clin Cancer Res Correction BioMed Central 2023-09-30 /pmc/articles/PMC10542228/ /pubmed/37775828 http://dx.doi.org/10.1186/s13046-023-02824-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Teng, Fei Zhang, Ju-Xiang Chang, Qi-Meng Wu, Xu-Bo Tang, Wei-Guo Wang, Jian-Fa Feng, Jin-Feng Zhang, Zi-Ping Hu, Zhi-Qiu Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma |
| title | Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma |
| title_full | Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma |
| title_fullStr | Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma |
| title_full_unstemmed | Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma |
| title_short | Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma |
| title_sort | correction: lncrna mylk-as1 facilitates tumor progression and angiogenesis by targeting mir-424-5p/e2f7 axis and activating vegf r-2 signaling pathway in hepatocellular carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542228/ https://www.ncbi.nlm.nih.gov/pubmed/37775828 http://dx.doi.org/10.1186/s13046-023-02824-9 |
| work_keys_str_mv | AT tengfei correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT zhangjuxiang correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT changqimeng correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT wuxubo correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT tangweiguo correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT wangjianfa correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT fengjinfeng correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT zhangziping correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma AT huzhiqiu correctionlncrnamylkas1facilitatestumorprogressionandangiogenesisbytargetingmir4245pe2f7axisandactivatingvegfr2signalingpathwayinhepatocellularcarcinoma |